Supreme Court

SCOTUS Won't Hear Philly Case in Dispute Over Supervised Injection Sites

NBC Universal, Inc.

What to Know

  • The U.S. Supreme Court won’t review a nonprofit group’s effort to open a supervised injection site in Philadelphia to try to reduce overdose deaths. The high court’s decision Wednesday in the widely watched test case is a setback for the two dozen U.S. states and cities that supported the petition.
  • Organizers of the Safehouse project say federal laws are not intended to criminalize medically supervised centers. Safehouse vice president Ronda Goldfein says the fight is not over.
  • The U.S. tallied more than 93,000 overdose deaths last year, according to CDC data.

The U.S. Supreme Court decided Wednesday it will not review a nonprofit group's effort to open a supervised injection site in Philadelphia to try to reduce overdose deaths. The high court's decision in the widely watched test case is a setback for the two dozen U.S. states and cities that supported the petition.

A divided U.S. appeals court had rejected the Safehouse plan in January. Organizers of the Safehouse project say federal “crackhouse” laws enacted are not intended to criminalize medically supervised centers.

Safehouse vice president Ronda Goldfein tells The Philadelphia Inquirer the fight is not over. She hopes they can prevail on religious grounds by arguing that their faith compels them to try to save lives.

A trial judge had sided with Safehouse in the case, but the federal appeals court overturned the decision and sided with the Republican Justice Department in declaring the plan illegal.

The Justice Department under President Joe Biden has so far stayed neutral in the litigation.

The U.S. tallied more than 93,000 overdose deaths last year, according to CDC data.

The debate over supervised injection sites continued during Mayor Kenney's budget plan speech at city hall on Thursday. Groups on both sides of the issue let their voices be heard. NBC10's Matt DeLucia has the details.
Copyright AP - Associated Press
Contact Us